Detalhe da pesquisa
1.
CTNNB1 (beta-catenin) mutation identifies low grade, early stage endometrial cancer patients at increased risk of recurrence.
Mod Pathol;
30(7): 1032-1041, 2017 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28281553